ROBERT LOGAN AVERY, M.D.
Medical Practice at Micheltorena St, Santa Barbara, CA

License number
California A52052
Category
Medical Practice
Type
Specialist
Address
Address
515 E Micheltorena St SUITE C, Santa Barbara, CA 93103
Phone
(805) 963-1648
(805) 965-5214 (Fax)

Professional information

Robert Avery Photo 1

Dr. Robert Avery - MD (Doctor of Medicine)

Hospitals:
5329 Office Center Ct STE 120, Bakersfield 93309
1801 Solar Dr, Oxnard 93030
1510 E Main St STE 103, Santa Maria 93454
California Retina Consultants
515 E Micheltorena St STE C, Santa Barbara 93103
Sansum Clinic, Ophthalmology
29 W Anapamu St, Santa Barbara 93101
Marian Regional Medical Center
1400 East Church St, Santa Maria 93454
5329 Office Center Ct STE 120, Bakersfield 93309
1801 Solar Dr, Oxnard 93030
1510 E Main St STE 103, Santa Maria 93454
California Retina Consultants
515 E Micheltorena St STE C, Santa Barbara 93103
Sansum Clinic, Ophthalmology
29 W Anapamu St, Santa Barbara 93101
Marian Regional Medical Center
1400 East Church St, Santa Maria 93454
Education:
Medical Schools
Johns Hopkins University School Of Medicine
Graduated: 1987


Robert Avery Photo 2

Implantable Delivery Device For Administering Pharmacological Agents To An Internal Portion Of A Body

US Patent:
2006025, Nov 16, 2006
Filed:
May 1, 2006
Appl. No.:
11/415054
Inventors:
Robert Avery - Santa Barbara CA, US
International Classification:
A61M 35/00
US Classification:
604294000
Abstract:
An implantable refillable device to deliver pharmacologic agents through a sclera to an internal portion of an eye is shown. The device comprises a hollow reservoir and a delivery tube. The delivery tube has a proximal end and a distal end. The proximal end communicates with the hollow reservoir and the distal end terminates in a dispensing outlet. The delivery tube is configured in a selected shape to extend from the hollow reservoir anterior in an eye to a posterior segment posterior in an eye adjoining a sclera. The second end is configured to position the dispensing outlet in contact with or contiguous the sclera and is located posteriorly in an eye and proximate to an internal portion of an eye to be treated with a pharmacologic agent. An implantable device to deliver pharmacologic agents through an outer surface tissue of an organ is also shown.


Robert Logan Avery Photo 3

Robert Logan Avery, Santa Barbara CA

Specialties:
Ophthalmologist
Address:
515 E Micheltorena St, Santa Barbara, CA 93103
29 West Anapamu St., Santa Barbara, CA 93101
Education:
Johns Hopkins University, School of Medicine - Doctor of Medicine
Duke University Hospital - Fellowship - Vitreoretinal
Johns Hopkins Hospital - Residency - Ophthalmology
Board certifications:
American Board of Ophthalmology Certification in Ophthalmology


Robert Avery Photo 4

Ceo At Crc

Position:
ceo at crc
Location:
Santa Barbara, California Area
Industry:
Medical Practice
Work:
crc - ceo


Robert Avery Photo 5

Intravitreal Medicine Delivery

US Patent:
6251090, Jun 26, 2001
Filed:
Nov 2, 1998
Appl. No.:
9/184925
Inventors:
Robert Logan Avery - Santa Barbara CA
Jeffrey Kevin Luttrull - Ventura CA
International Classification:
A61M 500, A61M 3500
US Classification:
604 9
Abstract:
An intravitreal medicine delivery device and method are provided and include an implant device through which a wide variety of beneficial medicines including drugs or other pharmacological agents can be introduced into the vitreous cavity over an extended period of time with only a single initial surgery to implant the device. The device and method minimize the surgical incision needed for implantation and avoid future or repeated invasive surgery or procedures. Additional amounts of the initial medicine can readily be introduced or the medication can be varied or changed, as required. Furthermore, the device and method allow the dosage delivered to the vitreous cavity to be device is constructed so as to filter medicines delivered to the cavity and also avoids damage to or interference with other parts of the eye during implantation or during use.


Robert Avery Photo 6

Intravitreal Medicine Delivery

US Patent:
5830173, Nov 3, 1998
Filed:
Aug 1, 1997
Appl. No.:
8/904821
Inventors:
Robert Logan Avery - Santa Barbara CA
Jeffrey Kevin Luttrull - Ventura CA
International Classification:
A61M 500, A61M 3500
US Classification:
604 9
Abstract:
An intravitreal medicine delivery device and method that includes an implant device through which a wide variety of beneficial medicines including drugs or other pharmacological agents can be introduced into the vitreous cavity over an extended period of time with only a single initial surgery to implant the device. The device and method minimize the surgical incision needed for implantation and avoid future or repeated invasive surgery or procedures. Additional amounts of the initial medicine can readily be introduced or the medication can be varied or changed, as required. Furthermore, the device and method allow the dosage delivered to the vitreous cavity to be controlled, and the device is constructed so as to filter medicines delivered to the cavity and also avoids damage to or interference with other parts of the eye during implantation or during use.


Robert Avery Photo 7

Intravitreal Medicine Delivery

US Patent:
5725493, Mar 10, 1998
Filed:
Dec 12, 1994
Appl. No.:
8/353804
Inventors:
Robert Logan Avery - Santa Barbara CA
Jeffrey Kevin Luttrull - Ventura CA
International Classification:
A61M 500, A61M 3500
US Classification:
604 9
Abstract:
An intravitreal medicine delivery device and method that includes an implant device through which a wide variety of beneficial medicines including drugs or other pharmacological agents can be introduced into the vitreous cavity over an extended period of time with only a single initial surgery to implant the device. The device and method minimize the surgical incision needed for implantation and avoid future or repeated invasive surgery or procedures. Additional amounts of the initial medicine can readily be introduced or the medication can be varied or changed, as required. Furthermore, the device and method allow the dosage delivered to the vitreous cavity to be controlled, and the device is constructed so as to filter medicines delivered to the cavity and also avoids damage to or interference with other parts of the eye during implantation or during use.